Leogenic Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 2.50 Cr
- Revenue Growth 4238.72%
- Profit Growth 109.39%
- Ebitda 117.88%
- Net Worth 9.56%
- Total Assets 220.46%
About Leogenic Healthcare
Leogenic Healthcare Private Limited (LHPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2018 (Six years and ten months 8 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.50 Cr.
Venu Narayana and Jagarlamudi Lakshmi serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85320MH2018PTC308093
- Company No.
308093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2018
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Leogenic Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venu Narayana  | Director | 16-Apr-2018 | Current |
| Jagarlamudi Lakshmi | Director | 02-Nov-2018 | Current |
Financial Performance of Leogenic Healthcare.
Leogenic Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 4238.72% increase. The company also saw a substantial improvement in profitability, with a 109.39% increase in profit. The company's net worth moved up by a moderate rise of 9.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leogenic Healthcare?
In 2020, Leogenic Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Leogenic Pharma Private LimitedVenu Narayana and Jagarlamudi Lakshmi are mutual person
Charges (Loans)
₹2.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Sep 2020 | Canara Bank | ₹2.50 Cr | Open |
How Many Employees Work at Leogenic Healthcare?
Leogenic Healthcare has a workforce of 54 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leogenic Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leogenic Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
